 The research funded by the charity has enabled more people than ever before to survive blood cancer.The survival rate for the most common form of childhood leukaemia has increased to over 90%, and for adults the survival rate is now as high as 70-80% for some forms of blood cancer.In 2011 the charity launched a Trials Acceleration Programme (TAP) to enable quicker and greater access to new treatments which has subsequently received government recognition as a model of good practice.